RASSF3-GYS2 Fusion FISH Probe
The RASSF3-GYS2 Fusion FISH Probe is used to confirm a fusion of the RASSF3 and GYS2 genes. The fusion of the RASSF3 and GYS2 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| RASSF3-GYS2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| RASSF3-GYS2-20-AQAQ | 20 (40 μL) | 200 μL |
|
GYS2 Gene Summary
The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
Gene Name: Glycogen Synthase 2
Chromosome: CHR12: 21689122 -21757781
Locus: 12p12.1
RASSF3 Gene Summary
The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. Members of the RAS superfamily are plasma membrane GTP-binding proteins that modulate intracellular signal transduction pathways. A subfamily of RAS effectors, including RASSF3, share a RAS association (RA) domain.[supplied by OMIM, Jul 2003]
Gene Name: Ras Association Domain Family Member 3
Chromosome: CHR12: 65004292 -65091347
Locus: 12q14.2
Gene Diseases
The RASSF3 GYS2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|